Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by Chritterson Oct 04, 2020 10:20am
224 Views
Post# 31664257

RE:RE:What is everyone's Thoughts on this situation now?

RE:RE:What is everyone's Thoughts on this situation now?
Very good points and your right, We are all kind of stuck if you want to sell as you have to wait til this halt starts up if your thinking of selling but you cant even set your TFSA acct to sell at 0.025, so it plumments from the start were all screwed I think we are going to see a Class action suit over this BS. Lot of people may be out of a lot of money



Captainblk wrote:
I've been invested in kly for a few years now. I've got a comfortable average, but at its current SP it still represents a loss. I was invested because the info I was presented made dollars and cents. What I keep circling back to lately is that we were not in the midst of a global pandemic what would kly have to offer us? We gave up the one thing many of us invested into. Add to the fact that we have been halted for some time because This company failed to do what I consider the bare minimum, which was get their homework into teacher on time. This reeks of mismanagement to me. I don't have much faith in the r107, simply for the fact that with the world so active in finding anything to combat covid, there would be some deep pocket beating down our doors for a piece of what we got (which isn't much) If and when we unhalt we are reaaaaaaaaally going to bottom out unless we have some miracle before then. But for how shady Bob now is in my eyes I don't believe he has SH in his best interest. It's going to take some strong evidence and more importantly results that management has been working for us to change my views. Not just wishful ideas and insinuating potential. They did that with GVHD and we saw no return on that. Right now I'm leaning towards sell until proven otherwise


<< Previous
Bullboard Posts
Next >>